Ms Sharon Foley:

I think there is a mixture of all of that. If we look at other countries like Canada, and at Scotland and Wales, they are on a journey. Some of their expansion and development has happened over the last 20 or 30 years, so change happens slowly. As I said earlier, at this stage, we are so far behind that we need to try to speed up. There is a huge role for this committee in asking the right questions, in keeping the pressure and attention on it and to keep naming the need for a national pharmaceutical strategy and the development of some of the ideas we have shown. There will always be some levels of resistance because health systems in general resist change. It has to do with power and where things move. Other countries have shown it can be done and it certainly benefits the citizens of those countries, so it should be done.